Bayesian Design of Clinical Trials Using Joint Cure Rate Models for Longitudinal and Time-to-Event Data

Jiawei Xu (), Matthew A. Psioda () and Joseph G. Ibrahim ()
Additional contact information
Jiawei Xu: University of North Carolina at Chapel Hill
Matthew A. Psioda: University of North Carolina at Chapel Hill
Joseph G. Ibrahim: University of North Carolina at Chapel Hill

Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data, 2023, vol. 29, issue 1, No 8, 213-233

Abstract: Abstract For clinical trial design and analysis, there has been extensive work related to using joint models for longitudinal and time-to-event data without a cure fraction (i.e., when all patients are at risk for the event of interest), but comparatively little treatment has been given to design and analysis of clinical trials using joint models that incorporate a cure fraction. In this paper, we develop a Bayesian clinical trial design methodology focused on evaluating the treatment’s effect on a time-to-event endpoint using a promotion time cure rate model, where the longitudinal process is incorporated into the hazard model for the promotion times. A piecewise linear hazard model for the period after assessment of the longitudinal measure ends is proposed as an alternative to extrapolating the longitudinal trajectory. This may be advantageous in scenarios where the period of time from the end of longitudinal measurements until the end of observation is substantial. Inference for the time-to-event endpoint is based on a novel estimand which combines the treatment’s effect on the probability of cure and its effect on the promotion time distribution, mediated by the longitudinal outcome. We propose an approach for sample size determination such that the design has a high power and a well-controlled type I error rate with both operating characteristics defined from a Bayesian perspective. We demonstrate the methodology by designing a breast cancer clinical trial with a primary time-to-event endpoint where longitudinal outcomes are measured periodically during follow up.

Keywords: Bayesian design; Clinical trials; Joint cure rate models; Longitudinal outcomes; Sampling prior (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10985-022-09581-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:lifeda:v:29:y:2023:i:1:d:10.1007_s10985-022-09581-5

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/10985

DOI: 10.1007/s10985-022-09581-5

Access Statistics for this article

Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data is currently edited by Mei-Ling Ting Lee

More articles in Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().